Please login to the form below

Not currently logged in
Email:
Password:

Medical device M&A hit 'all-time high' in 2014

Deals last year were led by Medtronic’s acquisition of Covidien

Medtronic headquarters 

Mergers and acquisitions in the medical devices industry hit an all-time high last year, led by Medtronic's acquisition of Covidien - a deal that created the sector's largest company.

Analysis by GlobalData put 2014's M&A activity up 18.5% compared to 2013, with 96 mergers and acquisitions announced during the last 12 months.

Niharika Midha, GlobalData's medical devices analyst, said: “A considerable number of deals in 2014 involved larger companies swallowing up smaller ones with novel technologies that were clinically proven to be superior to existing devices.

“This sets the tone for the coming years, as the medical device industry consolidates into fewer prominent players that directly compete with each other and innovation is fuelled by heightened demand.”

The largest deal of the year was Medtronic's $42.9bn acquisition of Covidien, which faced some criticism that it was motivated by tax inversion, though some analysts have suggested the move was a tactical one, given Covidien's established status in the sector.

Covidien has been expanding its business in patient monitoring and hospital services, including generating promising revenue.

Midha noted that companies with an extensive product portfolio tend to have a competitive advantage in the current industry trends.

She added: “The demand side is displaying an increasing preference for manufacturers that offer a one-stop solution for all their needs.”

The spike in medical devices activity in 2014 mirrors that seen in the pharma sector, where last year's deals included Merck's $9.5bn acquisition of Cubist in addition to paying $3.85bn for Idenix Pharmaceuticals.

Article by
Kirstie Pickering

15th January 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics